Gold Cross Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 03-04-2024
- Paid Up Capital ₹ 0.99 M
as on 03-04-2024
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2014
- Satisfied Charges ₹ 4.50 M
as on 03-04-2024
About Gold Cross Laboratories
- CIN/LLPIN
U24230MH1983PTC029606
- Company No.
029606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1983
- Date of AGM
25 Apr 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gold Cross Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhalchandra Govind  | Director | 15-May-1996 | Current |
| Nihchal Israni | Director | 23-Mar-1983 | Current |
| Manoj Israni | Director | 06-Aug-1998 | Current |
| Suresh Mahalingam | Director | 18-Jan-2011 | Current |
| Haresh Sheth | Director | 18-Jan-2011 | Current |
Financial Performance and Corporate Structure Insights of Gold Cross Laboratories.
Enhance accessibility to Gold Cross Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gold Cross Laboratories?
Unlock access to Gold Cross Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Blue Cross Laboratories Private LimitedActive 44 years 5 monthsNihchal Israni, Manoj Israni and 1 more are mutual person
Hariman Laboratories Pvt LtdActive 35 years 4 monthsNihchal Israni, Manoj Israni and 1 more are mutual person
- Nihchal Israni FoundationActive 11 years 4 months
Nihchal Israni, Manoj Israni and 1 more are mutual person
- Niko Management Services Private LimitedActive 34 years 10 months
Manoj Israni and Suresh Mahalingam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 12 Jun 1998 | ₹4.00 M | Satisfied |
Bank Of America Creation Date: 09 Sep 1985 | ₹0.50 M | Satisfied |
How Many Employees Work at Gold Cross Laboratories?
Gold Cross Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gold Cross Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gold Cross Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
